Impact of mediators present in amniotic fluid on preterm labour

In Vivo

Volumn 26, Issue 5, 2012, Pages 799-812

  Vrachnis, Nikolaos ^a   Karavolos, Stamatios ^b   Iliodromiti, Zoe ^a   Sifakis, Stavros ^c   Siristatidis, Charalambos ^d   Mastorakos, George ^a   Creatsas, George ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^d UNIVERSITY OF ATHENS   (Greece)

Author keywords

Amniotic fluid; Cell adhesion molecules; Cytokines; Immune regulation; Interleukins; Leukotrienes; Mediators; Preterm labour; Prostaglandins; Review

Indexed keywords

ARACHIDONIC ACID; BIOLOGICAL MARKER; CELL ADHESION MOLECULE; CYTOKINE; GELATINASE B; HYDROXYICOSATETRAENOIC ACID; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOTRIENE; LEUKOTRIENE B4; LEUKOTRIENE C4; MATRIX METALLOPROTEINASE; METALLOPROTEINASE; NEUTROPHIL COLLAGENASE; NITRIC OXIDE; PROSTAGLANDIN; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNINDEXED DRUG; AUTACOID; SCLEROPROTEIN;

AMNION FLUID; ANGIOGENESIS; ARACHIDONIC ACID METABOLISM; CELL FUNCTION; CHEMOTAXIS; CYTOKINE PRODUCTION; ECHOGRAPHY; ETHNIC GROUP; EXTRACELLULAR MATRIX; FETUS MEMBRANE; GENOTYPE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INFECTION; INFLAMMATION; MEDIATOR; MOLECULAR MECHANICS; NONHUMAN; OLIGOHYDRAMNIOS; PREGNANT WOMAN; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PROSTAGLANDIN SYNTHESIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RACE DIFFERENCE; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; UTERUS CONTRACTILITY; ANIMAL; FEMALE; LABOR; METABOLISM; PREGNANCY; PREMATURITY;

AMNIOTIC FLUID; ANIMALS; CELL ADHESION MOLECULES; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LABOR, OBSTETRIC; PREGNANCY; PREMATURE BIRTH;

EID: 84866617181     PISSN: 0258851X     EISSN: 17917549     Source Type: Journal    
DOI: None     Document Type: Review

References (139)

1. Vrachnis N, Botsis D and Iliodromiti Z: The fetus that is small for gestational age. Ann N Y Acad Sci 1092: 304-309, 2006. (Pubitemid 47092348)
2. Malamitsi-Puchner A, Economou E, Boutsikou T, Nikolaou KE and Vrachnis N: Neurotrophin-3 and FLT3 tyrosine kinase receptor in perinatal life. Mediators Inflamm 24;2005(1): 53-56, 2005.
3. Botsis D, Vrachnis N and Christodoulakos G: Doppler assessment of the intrauterine growth-restricted fetus. Ann N Y Acad Sci 1092: 297-303, 2006. (Pubitemid 47092347)
4. Vrachnis N, Malamas F, Sifakis S, Tsikouras P and Iliodromiti Z: Immune aspects and myometrial actions of progesterone and CRH in labor. Clin Dev Immunol 2012: 1-10, 2011.
5. Romero R, Mazor M, Munoz H, Gomez R, Galasso M and Sherer DM: The preterm labor syndrome. Ann NY Acad Sci 734: 414-429, 1994.
6. Hirsch E and Wang H: The molecular pathophysiology of bacterially induced preterm labor: insights from the murine model. J Soc Gynecol Investig 12: 145-155, 2005. (Pubitemid 40387807)
7. Menon R, Thorsen P, Vogel I, Jacobsson B, Morgan N, Jiang L, Li C, Williams SM and Fortunato SJ: Racial disparity in amniotic fluid concentrations of tumor necrosis factor (TNF)-alpha and soluble TNF receptors in spontaneous preterm birth. Am J Obstet Gynecol 198(5): 533 e1-10, 2008.
8. Menon R, Thorsen P, Vogel I, Jacobsson B, Morgan N, Jiang L, Li C, Williams SM, Fortunato SJ: Racial disparity in amniotic fluid concentrations of tumor necrosis factor (TNF)-a and soluble TNF receptors in spontaneous preterm birth. Am J Obstet Gynecol 198: 1-10, 2008.
9. Svigos J M, Robinson J S and Vigneswaran R: Threatened and actual preterm labour including mode of delivery. In: High risk pregnancy: Management options. 3rd edition, Elsevier Saunders, 2006.
10. Vrachnis N, Vitoratos N, Iliodromiti Z, Sifakis S, Deligeoroglou E and Creatsas G: Intrauterine inflammation and preterm delivery. Ann NY Acad Sci 1205: 118-122, 2010.
11. Gibbs RS, Romero R, Hillier SL, Eschenbach DA and Sweet RL: A review of premature birth and subclinical infection. Am J Obstet Gynaecol 166: 1515, 1992.
12. Bennett P, Allport V, Loudon J and Elliott C: Prostaglandins, the fetal membranes and the cervix. Front Horm Res 27: 147-164, 2001. (Pubitemid 33816370)
13. Kobayashi K, Miwa H and Yasui M: Inflammatory mediators weaken the amniotic membrane barrier through disruption of tight junctions. J Physiol 588(24): 4859-4869, 2010.
14. Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M and Berry SM: The fetal inflammatory response syndrome. Am J Obstet Gynecol 179(1): 194-202, 1998. (Pubitemid 28394495)
15. Bangiolini M, Dewald B and Moser B: Human chemokines: an update. Ann Rev Immunol 15: 675-677, 1997.
16. Oliver R and Lamount R: Role of cytolkines in spontaneous preterm labour and preterm birth. In: Progress in obstetrics and gynaecology, 16, Elsevier, 2003.
17. Christiaens I, Zaragoza DB, Guilbert L, Robertson SA, Mitchell BF and Olson DM: Inflammatory processes in preterm and term parturition. J Reprod Immunol 79(1): 50-57, 2008.
18. Menon R, Fortunato SJ, Edwards DR and Williams SM: Association of genetic variants, ethnicity and preterm birth with amniotic fluid cytokine concentrations. Ann Hum Genet 74(2): 165-183, 2010.
19. Edwin SS, Romero RJ, Munoz H, Branch DW and Mitchell MD: 5-Hydroxyeicosatetraenoic acid and human parturition. Prostaglandins 51(6): 403-412, 1996. (Pubitemid 26279752)
20. Arntzen KJ, Kjøllesdal AM, Halgunset J, Vatten L and Austgulen R: TNF, IL-1, IL-6, IL-8 and soluble TNF receptors in relation to chorioamnionitis and premature labor. J Perinat Med 26(1): 17-26, 1998. (Pubitemid 28154324)
21. Hayashi M, Zhu K, Sagesaka T, Fukasawa I and Inaba N: Amniotic fluid levels of tumor necrosis factor-alpha and soluble tumor necrosis factor receptor 1 before and after the onset of labor in normal pregnancies. Horm Metab Res 40(4): 251-256, 2008. (Pubitemid 351533107)
22. Dudley DJ and Trautman MS: Infection, inflammation, and contractions: the role of cytokines in the pathophysiology of preterm labor. Sem Reprod Endocrinol 12: 263-272, 1994.
23. Hillier SL, Witkin SS, Krohn MA, Watts DH, Kiviat NB and Eschenbach DA: The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstetrics and Gynecology 81: 941-948, 1993. (Pubitemid 23168738)
24. Gravett MG, Witkin SS and Novy MD: A nonhumanprimate model for chorioamnionitis and preterm labor. Sem Reprod Endocrinol 12: 246-262, 1994.
25. 2 synthesis by amnion cells in culture: regulation by tumour necrosis factor alpha, TGF-a, and interleukin-1 receptor agonist. Biochimica et Biophysica Acta 1181: 31-36, 1993.
26. Keelan JA, Sato T and Mitchell MD: Interleukin (IL)-6 and IL-8 production by human amnion: regulation by cytokines, growth factors, glucocorticoids, phorbol esters, and bacterial lipopolysaccharide. Biol Reprod 57(6): 1438-1444, 1997. (Pubitemid 27516650)
27. Kacerovský M, Drahosová M, Hornychová H, Plísková L, Bolehovská R, Förstl M, Tosner J, Lesko D and Andrýs C: Amniotic fluid interleukin 6 levels in preterm premature rupture of membranes. Ceska Gynekol 74(6): 403-410, 2009.
28. Marconi C, de Andrade Ramos BR, Peraçoli JC, Donders GG and da Silva MG: Amniotic fluid interleukin-1 beta and interleukin-6, but not interleukin-8 correlate with microbial invasion of the amniotic cavity in preterm labor. Am J Reprod Immunol 65(6): 549-56, 2011.
29. Laham N, Brennecke SP, Bendtzen K and Rice GE: Tumour necrosis factor alpha during human pregnancy and labour: maternal plasma and amniotic fluid concentrations and release from intrauterine tissues. Eur J Endocrinol 131(6): 607-614, 1994. (Pubitemid 24377192)
30. Maymon E, Ghezzi F, Edwin SS, Mazor M, Yoon BH, Gomez R and Romero R: The tumor necrosis factor alpha and its soluble receptor profile in term and preterm parturition. Am J Obstet Gynecol 181(5 Pt 1): 1142-1118, 1999.
31. Yoon BH, Kim YA, Romero R, Kim JC, Park KH, Kim MH and Park JS: Association of oligohydramnios in women with preterm premature rupture of membranes with an inflammatory response in fetal, amniotic, and maternal compartments. Am J Obstet Gynecol 181(4): 784-788, 1999. (Pubitemid 29503591)
32. Bazzoni F, Beutler B, Flier J and Underhill L: The tumor necrosis factor ligand and receptor families. N Engl J Med 334:1717-1724, 1996.
33. Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV and Boldin MP: Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 17: 331-367, 1999. (Pubitemid 29241128)
34. Buckley CA, Rouhani FN, Kaler M, Adamik B, Hawari FL and Levine SJ: Amino-terminal TACE prodomain attenuates TNFR2 cleavage independently of the cysteine switch. Am J Physiol Lung Cell Mol Physiol 288: L1132-1118, 2005.
35. Reddy P, Slack JL, Davis R, Cerretti DP, Kozlosky CJ, Blanton RA et al: Functional analysis of the domain structure of tumor necrosis factor - alpha converting enzyme. J Biol Chem 275:14608-14614, 2000. (Pubitemid 30339751)
36. Hillier SL, Witkin SS, Krohn MA, Watts DH, Kiviat NB and Eschenbach DA: The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstet Gynecol 81: 941-948, 1993. (Pubitemid 23168738)
37. Arntzen KJ, Kjøllesdal AM, Halgunset J, Vatten L and Austgulen R: TNF, IL-1, IL-6, IL-8 and soluble TNF receptors in relation to chorioamnionitis and premature labor. J Perinat Med 26(1): 17-26, 1998. (Pubitemid 28154324)
38. Weiyuan Z and Li W: Study of interleukin-6 and tumor necrosis factor-alpha levels in maternal serum and amniotic fluid of patients with premature rupture of membranes. J Perinat Med 26(6): 491-494, 1998.
39. Yoon BH, Romero R, Park JS, Chang JW, Kim YA, Kim JC and Kim KS: Microbial invasion of the amniotic cavity with Ureaplasma urealyticum is associated with a robust host response in fetal, amniotic, and maternal compartments. Am J Obstet Gynecol 179(5): 1254-1260, 1998. (Pubitemid 28533782)
40. Thomakos N, Daskalakis G, Papapanagiotou A, Papantoniou N, Mesogitis S and Antsaklis A: Amniotic fluid interleukin-6 and tumor necrosis factor-alpha at mid-trimester genetic amniocentesis: relationship to intra-amniotic microbial invasion and preterm delivery. Eur J Obstet Gynecol Reprod Biol 148(2): 147-151, 2010.
41. Menon R, Velez DR, Morgan N, Lombardi SJ, Fortunato SJ and Williams SM: Genetic regulation of amniotic fluid TNF-alpha and soluble TNF receptor concentrations affected by race and preterm birth. Hum Genet 124(3): 243-253, 2008.
42. Romero R, Wu YK, Mazor M, Oyarzun E, Hobbins JC and Mitchell MD: Amniotic fluid arachidonate lipoxygenase metabolites in preterm labor. Prostaglandins Leukot Essent Fatty Acids 36(2): 69-75, 1989. (Pubitemid 19121856)
43. Park KH, Chaiworapongsa T, Kim YM, Espinoza J, Yoshimatsu J, Edwin S, Gomez R, Yoon BH and Romero R: Matrix metalloproteinase 3 in parturition, premature rupture of the membranes, and microbial invasion of the amniotic cavity. J Perinat Med 31(1): 12-22, 2003. (Pubitemid 36286020)
44. Weiss A, Goldman S and Shalev E: The matrix metalloproteinases (MMPS) in the decidua and fetal membranes. Front Biosci 12: 649-659, 2007. (Pubitemid 46860207)
45. Yoon BH, Oh SY, Romero R, Shim SS, Han SY, Park JS and Jun JK: An elevated amniotic fluid matrix metalloproteinase-8 level at the time of mid-trimester genetic amniocentesis is a risk factor for spontaneous preterm delivery. Am J Obstet Gynecol 185(5): 1162-1167, 2001. (Pubitemid 33097381)
46. Vadillo-Ortega F and Estrada-Gutiérrez G: Role of matrix metalloproteinases in preterm labour. BJOG 112(Suppl 1): 19-22, 2005. (Pubitemid 40313976)
47. Vaisbuch E, Hassan SS, Mazaki-Tovi S, Nhan-Chang CL, Kusanovic JP, Chaiworapongsa T, Dong Z, Yeo L, Mittal P, Yoon BH and Romero R: Patients with an asymptomatic short cervix (
48. Harirah H, Donia SE and Hsu CD: Amniotic fluid matrix metalloproteinase-9 and interleukin-6 in predicting intraamniotic infection. Obstet Gynecol 99(1): 80-84, 2002. (Pubitemid 34075473)
49. Uchide K, Ueno H, Inoue M, Sakai A, Fujimoto N and Okada Y: Matrix metalloproteinase-9 and tensile strength of fetal membranes in uncomplicated labor. Obstet Gynecol 95: 851-855, 2000.
50. Arechavaleta-Velasco F, Ogando D, Parry S and Vadillo-Ortega F: Production of matrix metalloproteinase-9 in lipopolysaccharide-stimulated human amnion occurs through an autocrine and paracrine proinflammatory cytokine-dependent system. Biol Reprod 67: 1952-1958, 2002. (Pubitemid 35388027)
51. Wang HL, Zhou C and Zhang YZ: Role of matrix metalloproteinase-2,9 and their inhibitors in premature rupture of membranes. Zhonghua Fu Chan Ke Za Zhi 40(1): 29-33, 2005.
52. Vadillo-Ortega F, Sadowsky D, Haluska G, Hernandez-Guerrero C, Guevara-Silva R, Gravett MG and Novy MJ: Identification of matrix metralloproteinase-9 in amniotic fluid and amniochorion in spontaneous labor and after experimental intrauterine infection or interleukin-1h infusion in pregnant rhesus monkeys. Am J Obstet Gynecol 186: 128-138, 2002. (Pubitemid 34093753)
53. Malamitsi-Puchner A, Vrachnis N, Samoli E, Baka S, Iliodromiti Z, Puchner KP, Malligianis P and Hassiakos D: Possible early prediction of preterm birth by determination of novel proinflammatory factors in midtrimester amniotic fluid. Ann NY Acad Sci 1092: 440-449, 2006. (Pubitemid 47092363)
54. Vrachnis N, Malamitsi-Puchner A, Samoli E, Botsis D, Iliodromiti Z, Baka S, Hassiakos D and Creatsas G: Elevated mid-trimester amniotic fluid ADAM-8 concentrations as a potential risk factor for preterm delivery. J Soc Gynecol Investig 13(3): 186-190, 2006.
55. Romero R, Mazor M, Brandt F, Sepulveda W, Avila C, Cotton DB and Dinarello CA: Interleukin-1 alpha and interleukin-1 beta in preterm and term human parturition. Am J Reprod Immunol 27(3-4): 117-123, 1992.
56. Romero R, Brody DT, Oyarzun E, Mazor M, Wu YK, Hobbins JC and Durum SK: Infection and labor. III. Interleukin-1: a signal for the onset of parturition. Am J Obstet Gynecol 160(5 Pt 1): 1117-1123, 1989. (Pubitemid 19144470)
57. Sadowsky DW, Adams KM, Gravett MG, Witkin SS and Novy MJ: Preterm labor is induced by intraamniotic infusions of interleukin-1beta and tumor necrosis factor-alpha but not by interleukin-6 or interleukin-8 in a nonhuman primate model. Am J Obstet Gynecol 195(6): 1578-1589, 2006. (Pubitemid 44792645)
58. Sadowsky DW, Novy MJ, Witkin SS and Gravett MG: Dexamethasone or interleukin-10 blocks interleukin-1beta-induced uterine contractions in pregnant rhesus monkeys. Am J Obstet Gynecol 188(1): 252-63, 2003. (Pubitemid 36135627)
59. Sadowsky DW, Haluska GJ, Gravett MG, Witkin SS and Novy MJ. Indomethacin blocks interleukin 1beta-induced myometrial contractions in pregnant rhesus monkeys. Am J Obstet Gynecol 183(1): 173-80, 2000. (Pubitemid 30626046)
60. Kemp MW, Saito M, Nitsos I, Jobe AH, Kallapur SG and Newnham JP: Exposure to in utero lipopolysaccharide induces inflammation in the fetal ovine skin. Reprod Sci 18(1): 88-98, 2011.
61. Vadillo-Ortega F, Sadowsky DW, Haluska GJ, Hernandez-Guerrero C, Guevara-Silva R, Gravett MG and Novy MJ: Identification of matrix metalloproteinase-9 in amniotic fluid and amniochorion in spontaneous labor and after experimental intrauterine infection or interleukin-1 beta infusion in pregnant rhesus monkeys. Am J Obstet Gynecol 186(1): 128-38, 2002. (Pubitemid 34093753)
62. Kumar D, Fung W, Moore RM, Pandey V, Fox J, Stetzer B, Mansour JM, Mercer BM, Redline RW and Moore JJ: Proinflammatory cytokines found in amniotic fluid induce collagen remodeling, apoptosis, and biophysical weakening of cultured human fetal membranes. Biol Reprod 74(1): 29-34, 2006. (Pubitemid 43068787)
63. Dudley DJ, Hunter C, Varner MW and Mitchell MD: Elevation of amniotic fluid interleukin-4 concentrations in women with preterm labor and chorioamnionitis. Am J Perinatol 13(7): 443-7, 1996. (Pubitemid 26425209)
64. Spaziani EP, Lantz ME, Benoit RR and O'Brien WF: The induction of cyclooxygenase-2 (COX-2) in intact human amnion tissue by interleukin-4. Prostaglandins 51(3): 215-223, 1996.
65. Le JM and Vilcek J: Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab Invest 61: 588-602, 1989.
66. Keelan JA, Sato TA, Gupta DK, Marvin KW and Mitchell MD: Prostanoid stimulation of cytokine production in an amnion-derived cell line: evidence of a feed-forward mechanism with implications for term and preterm labor. J Soc Gynecol Investig 7(1): 37-44, 2000. (Pubitemid 30109321)
67. Keelan JA, Sato T and Mitchell MD: Regulation of interleukin (IL)-6 and IL-8 production in an amnion-derived cell line by cytokines, growth factors, glucocorticoids, and phorbol esters. Am J Reprod Immunol 38(4): 272-278, 1997. (Pubitemid 27427420)
68. Wei SQ, Fraser W and Luo ZC: Inflammatory cytokines and spontaneous preterm birth in asymptomatic women: a systematic review. Obstet Gynecol 116(2 Pt 1): 393-401, 2010.
69. Krupa FG, Faltin D, Cecatti JG, Surita FG and Souza JP: Predictors of preterm birth. Int J Gynaecol Obstet 94(1): 5-11, 2006. (Pubitemid 43962994)
70. Vogel I, Thorsen P, Curry A, Sandager P and Uldbjerg N: Biomarkers for the prediction of preterm delivery. Acta Obstet Gynecol Scand 84(6): 516-525, 2005. (Pubitemid 40756419)
71. El-Bastawissi AY, Williams MA, Riley DE, Hitti J and Krieger JN: Amniotic fluid interleukin-6 and preterm delivery: a review. Obstet Gynecol 95: 1056-1064, 2000. (Pubitemid 30254495)
72. Wenstrom KD, Andrews WW, Hauth JC, Goldenberg RL, DuBard MB and Cliver SP: Elevated second-trimester amniotic fluid interleukin-6 levels predict preterm delivery. Am J Obstet Gynecol 178(3): 546-550, 1998. (Pubitemid 28207508)
73. Wenstrom KD, Andrews WW, Tamura T, DuBard MB, Johnston KE and Hemstreet GP: Elevated amniotic fluid interleukin-6 levels at genetic amniocentesis predict subsequent pregnancy loss. Am J Obstet Gynecol 175(4 Pt 1): 830-833, 1996. (Pubitemid 26357937)
74. Zhang W, Wang L, Zhao Y and Kang J: Changes in cytokine (IL-8, IL-6 and TNF-alpha) levels in the amniotic fluid and maternal serum in patients with premature rupture of the membranes. Zhonghua Yi Xue Za Zhi (Taipei) 63(4): 311-315, 2000. (Pubitemid 30262797)
75. Suzuki Y, Yamamoto T, Kojima K, Tanemura M, Tateyama H and Suzumori K: Evaluation levels of cytokines in amniotic fluid of women with intrauterine infection in the early second trimester. Fetal Diagn Ther 21(1): 45-50, 2006. (Pubitemid 41803423)
76. Figueroa R, Garry D, Elimian A, Patel K, Sehgal PB and Tejani N: Evaluation of amniotic fluid cytokines in preterm labor and intact membranes. J Matern Fetal Neonatal Med 18(4): 241-247, 2005. (Pubitemid 41770126)
77. Jacobsson B, Mattsby-Baltzer I and Hagberg H: Interleukin-6 and interleukin-8 in cervical and amniotic fluid: relationship to microbial invasion of the chorioamniotic membranes. BJOG 112(6): 719-724, 2005. (Pubitemid 40852838)
78. Holst RM, Mattsby-Baltzer I, Wennerholm UB, Hagberg H and Jacobsson B: Interleukin-6 and interleukin-8 in cervical fluid in a population of Swedish women in preterm labor: relationship to microbial invasion of the amniotic fluid, intra-amniotic inflammation, and preterm delivery. Acta Obstet Gynecol Scand 84(6): 551-557, 2005. (Pubitemid 40756428)
79. Jacobsson B, Mattsby-Baltzer I, Andersch B, Bokström H, Holst RM, Nikolaitchouk N, Wennerholm UB and Hagberg H: Microbial invasion and cytokine response in amniotic fluid in a Swedish population of women with preterm prelabor rupture of membranes. Acta Obstet Gynecol Scand 82(5): 423-431, 2003. (Pubitemid 36629849)
80. Romero R, Munoz H and Gomez R: Two thirds of spontaneous abortion/fetal deaths after genetic amniocentesis are the result of a pre-existing subclinical inflammatory process of the amniotic cavity. Am J Obstet Gynaecol 172: S261, 1995.
81. Wenstrom KD, Andrews WW, Tamura T, DuBard MB, Johnston KE and Hemstreet GP: Elevated amniotic fluid interleukin-6 levels at genetic amniocentesis predict subsequent pregnancy loss. Am J Obstet Gynecol 175: 830-833, 1996. (Pubitemid 26357937)
82. Menon R, Camargo MC, Thorsen P, Lombardi SJ and Fortunato SJ: Amniotic fluid interleukin-6 increase is an indicator of spontaneous preterm birth in white but not black Americans. Am J Obstet Gynecol 198(1): 1-7, 2008.
83. Oláh KS, Vince GS, Neilson JP, Deniz G and Johnson PM: Interleukin-6, interferon-gamma, interleukin-8, and granulocyte-macrophage colony stimulating factor levels in human amniotic fluid at term. J Reprod Immunol 32(1): 89-98, 1996. (Pubitemid 26382103)
84. Lee KY, Jun HA, Kim HB and Kang SW: Interleukin-6, but not relaxin, predicts outcome of rescue cerclage in women with cervical incompetence. Am J Obstet Gynecol 191(3): 784-789, 2004.
85. Velez DR, Menon R, Thorsen P, Jiang L, Simhan H, Morgan N, Fortunato SJ and Williams SM: Ethnic differences in interleukin 6 (IL-6) and IL-6 receptor genes in spontaneous preterm birth and effects on amniotic fluid protein levels. Ann Hum Genet 71(Pt 5): 586-600, 2007. (Pubitemid 47087067)
86. Shobokshi A and Shaarawy M: Maternal serum and amniotic fluid cytokines in patients with preterm premature rupture of membranes with and without intrauterine infection. Int J Gynaecol Obstet 79(3): 209-215, 2002. (Pubitemid 35365773)
87. Witczak M, Torbé A and Czajka R: Maternal serum and amniotic fluid IL-1 alpha, IL-1 beta, IL-6 and IL-8 levels in preterm and term labor complicated by PROM. Ginekol Pol 74(10): 1343-1347, 2003.
88. Wang L, Zhang W and Wang Y: Study of interleukin-6 and tumor necrosis factor-alpha levels in maternal serum and amniotic fluid in patients with preterm premature rupture of membrane. Zhonghua Fu Chan Ke Za Zhi 33(6): 328-330, 1998.
89. Velez DR, Fortunato SJ, Williams SM and Menon R: Interleukin-6 (IL-6) and receptor (IL6-R) gene haplotypes associate with amniotic fluid protein concentrations in preterm birth. Hum Mol Genet 17(11): 1619-1630, 2008. (Pubitemid 351737166)
90. Kacerovsky M, Drahosova M, Hornychova H, Pliskova L, Bolehovska R, Forstl M, Tosner J and Andrys C: Value of amniotic fluid interleukin-8 for the prediction of histological chorioamnionitis in preterm premature rupture of membranes. Neuro Endocrinol Lett 30(6): 733-738, 2009.
91. Sadowsky DW, Novy MJ, Witkin SS and Gravett MG: Dexamethasone or interleukin-10 blocks interleukin-1beta-induced uterine contractions in pregnant rhesus monkeys. Am J Obstet Gynecol 188: 252-263, 2003. (Pubitemid 36135627)
92. Puchner K, Iavazzo C, Gourgiotis D, Boutsikou M, Baka S, Hassiakos D, Kouskouni E, Economou E, Malamitsi-Puchner A and Creatsas G: Mid-trimester amniotic fluid interleukins (IL-1β, IL-10 and IL-18) as possible predictors of preterm delivery. In Vivo 25(1): 141-148, 2011.
93. Gibb W: The role of prostaglandins in human parturition. Ann Med 30(3): 235-241, 1998.
94. Bennett PR, Elder MG and Myat L. The effects of lipoxygenase metabolites of arachidonic acid on human myometrial contractility. Prostaglandins 33: 837-844, 1987. (Pubitemid 18015862)
95. Furuta I, Yamada H, Sagawa T and Fujimoto S: Effects of inflammatory cytokines on prostaglandin E(2) production from human amnion cells cultured in serum-free condition. Gynecol Obstet Invest 49(2): 93-97, 2000. (Pubitemid 30102897)
96. Hansen WR, Sato T and Mitchell MD: Tumour necrosis factor-alpha stimulates increased expression of prostaglandin endoperoxide H synthase Type 2 mRNA in amnion-derived WISH cells. J Mol Endocrinol 20: 221-231, 1998. (Pubitemid 28189384)
97. Menon R, Fortunato SJ, Milne GL, Brou L, Carnevale C, Sanchez SC, Hubbard L, Lappas M, Drobek CO and Taylor RN: Amniotic fluid eicosanoids in preterm and term births: effects of risk factors for spontaneous preterm labor. Obstet Gynecol 118(1): 121-134, 2011.
98. Lee DC, Romero R, Kim JS, Yoo W, Lee J, Mittal P, Kusanovic JP, Hassan SS, Yoon BH and Kim CJ: Evidence for a spatial and temporal regulation of prostaglandinendoperoxide synthase 2 expression in human amnion in term and preterm parturition. J Clin Endocrinol Metab 95(9): E86-91, 2010.
99. Makino S, Zaragoza DB, Mitchell BF, Robertson S and Olson DM: Prostaglandin F2alpha and its receptor as activators of human decidua. Semin Reprod Med 25(1): 60-68, 2007. (Pubitemid 46147845)
100. Lee SE, Park IS, Romero R and Yoon BH: Amniotic fluid prostaglandin F2 increases even in sterile amniotic fluid and is an independent predictor of impending delivery in preterm premature rupture of membranes. J Matern Fetal Neonatal Med 22(10): 880-886, 2009.
101. Mitchell MD, Kraemer DL and Strickland DM: The human placenta: a major source of prostaglandin D2. Prostaglandins Leukotriene Med 8: 383-387, 1982. (Pubitemid 12119472)
102. Edwin SS, Mitchell MD and Dudley DJ: Action of immunoregulatory agents on 5-HETE production by cultured human amnion cells. J Reprod Immunol 36(1-2): 111-21, 1997. (Pubitemid 27511462)
103. Romero R, Wu YK, Mazor M, Hobbins JC and Mitchell MD: Amniotic fluid 5-hydroxyeicosatetraenoic acid in preterm labor. Prostaglandins 36(2): 179-189, 1988.
104. Romero R, Quintero R, Emamian M, Wan M, Grzyboski C, Hobbins JC and Mitchell MD: Arachidonate lipoxygenase metabolites in amniotic fluid of women with intra-amniotic infection and preterm labor. Am J Obstet Gynecol 157(6):1454-1460, 1987. (Pubitemid 18022876)
105. Sezen D, Perni U, Herway C, Bongiovanni AM, Skupski D and Witkin SS: Hyaluronan modulates pro-inflammatory immune activity in the mid-trimester amniotic cavity. J Reprod Immunol 82(1): 89-93, 2009
106. Hadar A, Ytzhaki O, Shani-Shrem N, Horowitz S, Mazor M and Horowitz S: Amniotic fluid intercellular adhesion molecule-1 is a marker for Ureaplasma infection in women with preterm labor. Am J Obstet Gynecol 195(6): 1601-1606, 2006. (Pubitemid 44792630)
107. Salafia CM, DeVore GR, Mainolfi E, Kelly J, Pezzullo JC and Rothlein R: Circulating intercellular adhesion molecule-1 in amniotic fluid, maternal serum alpha-fetoprotein levels, and intrauterine growth retardation. Am J Obs Gynecol 169(4): 830-834, 1993. (Pubitemid 23317513)
108. Marvin KW, Keelan JA, Sato TA, Coleman MA, McCowan LM, Miller HC and Mitchell MD: Enhanced expression of intercellular adhesion molecule-1 (ICAM-1) in amnion with term and preterm labour. Placenta 21(1): 115-121, 2000. (Pubitemid 30099503)
109. Malamitsi-Puchner A, Vrachnis N, Samoli E, Baka S, Alexandrakis G, Puchner KP, Iliodromiti Z and Hassiakos D: Investigation of midtrimester amniotic fluid factors as potential predictors of term and preterm deliveries. Mediators Inflamm 2006(4): 94381, 2006.
110. Marinoni E, Di Iorio R, Villaccio B, Alberini A, Rota F and Cosmi EV: Amniotic fluid nitric oxide metabolite levels and nitric oxide synthase localization in feto-placental tissues are modified in association with human labor. Eur J Obstet Gynecol Reprod Biol 89(1): 47-54, 2000. (Pubitemid 30103782)
111. Hsu CD, Meaddough E, Aversa K, Hong SF, Lee IS, Bahodo-Singh RO, Lu LC, Copel JA. Dual roles of amniotic fluid nitric oxide and prostaglandin E2 in preterm labor with intraamniotic infection. Am J Perinatol 15(12): 683-687, 1998. (Pubitemid 29191159)
112. Hsu CD, Meaddough E, Hong SF, Aversa K, Lu LC, Copel JA. Elevated amniotic fluid nitric oxide metabolites and interleukin-6 in intra-amniotic infection. J Soc Gynecol Investig 5(1): 21-24, 1998. (Pubitemid 28095986)
113. Norman JE and Osman I: Nitric oxide. In: Preterm Labour: Managing Risk in Clinical Practice. Norman JE and Greer I (Editors). Cambridge University Press, 2005.
114. Athayde N, Romero R, Maymon E, Gomez R, Pacora P, Araneda H and Yoon BH: A role for the novel cytokine RANTES in pregnancy and parturition. Am J Obstet Gynecol 181(4): 989-994, 1999. (Pubitemid 29503628)
115. Nwosu UC, Bolognese RJ, Wallach E and Bongiovanni AM: Amniotic fluid cortisol concentrations in normal labor, premature labor, and postmature pregnancy. Obstet Gynecol 49(6): 715-717, 1977. (Pubitemid 8131459)
116. Ohana E, Mazor M, Chaim W, Levy J, Sharoni Y, Leiberman JR and Glezerman M: Maternal plasma and amniotic fluid cortisol and progesterone concentrations between women with and without term labor. A comparison. J Reprod Med 41(2): 80-86, 1996. (Pubitemid 26067662)
117. Torricelli M, Voltolini C, Galleri L, Biliotti G, Giovannelli A, De Bonis M, De Pascalis F, Centini G and Petraglia F: Amniotic fluid urocortin, CRF, oestriol, dehydroepiandrosterone sulfate and cortisol concentrations at mid-trimester: putative relationship with preterm delivery. Eur J Obstet Gynecol Reprod Biol 146(2): 169-173, 2009.
118. Di Iorio R, Marinoni E, Letizia C, Villaccio B, Alberini A and Cosmi EV: Adrenomedullin production is increased in normal human pregnancy. Eur J Endocrinol 140(3): 201-206, 1999. (Pubitemid 29155577)
119. Marinoni E, Di Iorio R, Letizia C, Villaccio B, Scucchi L and Cosmi EV: Immunoreactive adrenomedullin in human fetoplacental tissues. Am J Obstet Gynecol 179(3 Pt 1): 784-787, 1998. (Pubitemid 28447265)
120. Macri CJ, Martínez A, Moody TW, Gray KD, Miller MJ, Gallagher M and Cuttitta F: Detection of adrenomedullin, a hypotensive peptide, in amniotic fluid and fetal membranes. Am J Obstet Gynecol 175(4 Pt 1): 906-911, 1996. (Pubitemid 26357953)
121. Iavazzo C, Tassis K, Gourgiotis D, Boutsikou M, Baka S, Hassiakos D, Hadjithomas A, Vrachnis N and Malamitsi-Puchner A: Adrenomedullin concentration in second trimester 30 amniotic fluid cannot be used as a predictor of preterm delivery. In Vivo 23(6): 1021-1026, 2009.
122. Malamitsi-Puchner A, Vrachnis N, Samoli E, Baka S, Hassiakos D and Creatsas G: Elevated second trimester amniotic fluid interferon gamma-inducible T-cell alpha chemoattractant concentrations as a possible predictor of preterm birth. J Soc Gynecol Investig 13(1): 25-29, 2006. (Pubitemid 43003563)
123. Malamitsi-Puchner A, Vrachnis N, Samoli E, Baka S, Iliodromiti Z, Puchner KP, Malligianis P and Hassiakos D: Possible early prediction of preterm birth by determination of novel proinflammatory factors in midtrimester amniotic fluid. Ann NY Acad Sci 1092: 440-449, 2006. (Pubitemid 47092363)
124. Boggess KA, Greig PC, Murtha AP, Jimmerson CE and Herbert WN: Maternal serum granulocyte-colony stimulating factor in preterm birth with subclinical chorioamnionitis. J Reprod Immunol 33(1): 45-52, 1997. (Pubitemid 27220157)
125. Calhoun DA, Chegini N, Polliotti BM, Gersting JA, Miller RK and Christensen RD: Granulocyte colony-stimulating factor in preterm and term pregnancy, parturition, and intra-amniotic infection. Obstet Gynecol 97(2): 229-34, 2001. (Pubitemid 32126338)
126. Saito S, Kasahara T, Kato Y, Ishihara Y and Ichijo M: Elevation of amniotic fluid interleukin 6 (IL-6), IL-8 and granulocyte colony stimulating factor (G-CSF) in term and preterm parturition. Cytokine 5(1): 81-88, 1993. (Pubitemid 23098838)
127. Pacora P, Maymon E, Gervasi MT, Gomez R, Edwin SS, Yoon BH and Romero R: Lactoferrin in intrauterine infection, human parturition, and rupture of fetal membranes. Am J Obstet Gynecol 183(4): 904-910, 2000.
128. Gulbis B, Jauniaux E, Decuyper J, Thiry P, Jurkovic D and Campbell S: Distribution of iron and iron-binding proteins in first-trimester human pregnancies. Obstet Gynecol 84(2): 289-293, 1994. (Pubitemid 24234845)
129. Otsuki K, Yoda A, Saito H, Mitsuhashi Y, Toma Y, Shimizu Y and Yanaihara T: Amniotic fluid lactoferrin in intrauterine infection. Placenta 20(2-3): 175-179, 1999. (Pubitemid 29121812)
130. Otsuki K, Yoda A, Toma Y, Shimizu Y, Saito H and Yanaihara T: Lactoferrin and interleukin-6 interaction in amniotic infection. Adv Exp Med 443: 267-271, 1998. (Pubitemid 28432196)
131. Heller KA, Greig PC and Heine RP: Amniotic-fluid Lactoferrin: a Marker for Subclinical Intraamniotic Infection Prior to 32 Weeks Gestation. Infect Dis Obstet Gynecol 3: 179-183, 1995. (Pubitemid 26174017)
132. Mazaki-Tovi S, Romero R, Vaisbuch E, Erez O, Chaiworapongsa T, Mittal P, Kim SK, Pacora P, Gotsch F, Dong Z, Hassan SS and Kusanovic JP: Maternal plasma visfatin in preterm labor. J Matern Fetal Neonatal Med 22(8): 693-704, 2009.
133. Mazaki-Tovi S, Romero R, Kusanovic JP, Erez O, Gotsch F, Mittal P, Than NG, Nhan-Chang CL, Hamill N, Vaisbuch E, Chaiworapongsa T, Edwin SS, Nien JK, Gomez R, Espinoza J, Kendal-Wright C, Hassan SS and Bryant-Greenwood G: Visfatin/Pre-B cell colony-enhancing factor in amniotic fluid in normal pregnancy, spontaneous labor at term, preterm labor and prelabor rupture of
134. Bryant-Greenwood GD, Yamamoto SY, Lowndes KM, Webster LE, Parg SS, Amano A, Bullesbach EE, Schwabe C and Millar LK: Human decidual relaxin and preterm birth. Ann NY Acad Sci 1041: 338-344, 2005. (Pubitemid 41132271)
135. Weiss G and Goldsmith L: Relaxin-related preterm birth. In: Preterm Birth: Mechanisms, Mediators, Prediction, Prevention and Interventions. F Petraglia, JF Strauss III, SG Gabbe and G Weiss, Editors. Informa, 2007.
136. Bryant-Greenwood GD, Kern A, Yamamoto SY, Sadowsky DW and Novy MJ: Relaxin and the human fetal membranes. Reprod Sci 14(8 Suppl): 42-45, 2007.
137. Bryant-Greenwood GD, Yamamoto SY, Lowndes KM, Webster LE, Parg SS, Amano A, Bullesbach EE, Schwabe C and Millar LK: Human decidual relaxin and preterm birth. Ann NY Acad Sci 1041: 338-344, 2005. (Pubitemid 41132271)
138. Bryant-Greenwood GD, Yamamoto SY, Sadowsky DW, Gravett MG and Novy MJ: Relaxin stimulates interleukin-6 and interleukin-8 secretion from the extraplacental chorionic cytotrophoblast. Placenta 30(7): 599-606, 2009.
139. Weiss G and Goldsmith LT: Mechanisms of relaxin-mediated premature birth. Ann NY Acad Sci 1041: 345-50, 2005. (Pubitemid 41132272)